Overview

Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To discover if the adding of a coxib increases the efficacy of the Aromasine.
Phase:
Phase 3
Details
Lead Sponsor:
ARCAGY/ GINECO GROUP
Treatments:
Celecoxib
Exemestane